Robert D. Hunt

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 385 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Clonidine Benefits Children with Attention Deficit Disorder and Hyperactivity: Report of a Double-Blind Placebo-Crossover Therapeutic Trial

Robert D. Hunt, Ruud B. Minderaa, Donald J. Cohen · Journal of the American Academy of Child Psychiatry · 1985 · 314 citations

Pharmacy, Pediatrics, Pharmacotherapy +14

An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder

Robert D. Hunt, Amy F.T. Arnsten, Matthew D. Asbell · Journal of the American Academy of Child & Adolescent Psychiatry · 1995 · 307 citations

Medicine, Pharmacology, Pharmacotherapy +10

Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

Josephine M. Bryant, Simon R. Harris, Julian Parkhill et al. · The Lancet Respiratory Medicine · 2013 · 218 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

Sven O. Friedrich, Andrea Rachow, Elmar Saathoff et al. · The Lancet Respiratory Medicine · 2013 · 190 citations · Full text

Medicine, Infectious Diseases, Diagnostic Microbiology +15